E-health and People Living With Major Neurocognitive Disorder - CARE© and ESOGER© Applications (TNCM)
Major Neurocognitive Disorder, Frailty
About this trial
This is an interventional other trial for Major Neurocognitive Disorder focused on measuring E-Health
Eligibility Criteria
Inclusion Criteria:
- Be 65 years old or older.
- Have been previously diagnosed of MNCD (major neurocognitive disorder).
- Have a caregiver.
- Live in Montreal.
- Live at home or in a residence for seniors (RPA) in a non-medicalized area.
- Have an internet connection.
- Have a computer, or a touch pad or a smart phone.
- Understand French or English orally and in writing. The speakers are French and/or English speaking, and the questionnaires are only available in these 2 languages.
Exclusion Criteria:
- Participate in a concurrent investigational clinical study, to avoid interference with our study
- Live in a Residential and Long-Term Care Center (CHSDL) or in a medical sector in an RPA
Sites / Locations
- CRIUGMRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention group
Control group
Phase 1 Participants will assess their health status, at home, at recruitment (M0) and at 3 months (M3) with CARE© with the help of their family caregivers. The principal investigator or a representative will contact them by phone within 5 days of the CARE© assessment to complete ESOGER. Phase 2 Participants will assess their health status, at home, at recruitment (M0), at 3 months (M3), and at 6 months (M6) on the CARE© application with the help of their family caregivers. An additional assessment will take place over the phone by the principal investigator or one of his representatives. If their health status is considered fragile, then individuals will be contacted by phone by the PI or one of his representatives to complete the ESOGER© questionnaire (at M0, M3 and M6).
Phase 1 Participants will assess their health status, by telephone, at recruitment (M0) and at 3 months (M3) with CARE© with the help of their family caregivers. The principal investigator or a representative will contact them by phone within 5 days of the CARE© assessment to complete ESOGER. Phase 2 Participants will assess their health status, at home, at recruitment (M0), at 3 months (M3), and at 6 months (M6) on the CARE© application with the help of their family caregivers. An additional assessment will take place over the phone by the principal investigator or one of his representatives. If their health status is considered fragile, then individuals will be contacted by phone by the PI or one of his representatives to complete the ESOGER© questionnaire (at M0, M3 and M6).